The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
zuo hai leng dong xiao rong shu zai gan zhong liu zhi liao zhong de lin chuang ying yong ji zhan wang
Author(s): 
Pages: 2481-2482
Year: Issue:  15
Journal: The Journal of Practical Medicine

Abstract: 尽管外科手术是原发性肝癌(primary liver cancer)的首选治疗方法,但确诊时大部分患者已达中晚期,仅约10%~20%的病例能获得手术切除,术后5年生存率在12%~39%左右.研究[1]显示,肿瘤负荷与患者生存期相关,且原发性肝癌对放疗、化疗不甚敏感,因此,对于不能切除或不愿意接受手术切除的肝癌患者积极采用针对局部病灶的微创消融治疗为主的综合治疗,能减少肿瘤产生的局部压迫、阻塞症状,减缓肿瘤迅速增大对肝功能的破坏,减轻症状,延长生存期.
Related Articles
No related articles found